Fusion Pharmaceuticals Inc. (FUSN)
NASDAQ: FUSN · IEX Real-Time Price · USD
21.42
-0.03 (-0.14%)
At close: May 6, 2024, 4:00 PM
21.31
-0.11 (-0.51%)
After-hours: May 6, 2024, 7:50 PM EDT
Fusion Pharmaceuticals Analyst Ratings
Total Analysts
12
Consensus Rating
Hold
Price Target
$20.86
Upside
-2.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 16, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $21 | Hold | Reiterates | $21 | -1.96% | Mar 21, 2024 |
| Wedbush | Wedbush | Hold Reiterates $24 | Hold | Reiterates | $24 | +12.04% | Mar 21, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $16 → $21 | Buy → Hold | Downgrades | $16 → $21 | -1.96% | Mar 20, 2024 |
| Raymond James | Raymond James | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 20, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $13 → $23 | Strong Buy → Hold | Downgrades | $13 → $23 | +7.38% | Mar 20, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $11 → $21 | Strong Buy → Hold | Downgrades | $11 → $21 | -1.96% | Mar 20, 2024 |
| JonesTrading | JonesTrading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 20, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $11 → $21 | Strong Buy → Hold | Downgrades | $11 → $21 | -1.96% | Mar 19, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 19, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 19, 2024 |
| Raymond James | Raymond James | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 19, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $10 → $21 | Strong Buy → Hold | Downgrades | $10 → $21 | -1.96% | Mar 19, 2024 |
| Wedbush | Wedbush | Buy → Hold Downgrades $24 | Buy → Hold | Downgrades | $24 | +12.04% | Mar 19, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $17 → $21 | Buy → Hold | Downgrades | $17 → $21 | -1.96% | Mar 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $12 → $16 | Buy | Maintains | $12 → $16 | -25.30% | Mar 4, 2024 |
| Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | -39.31% | Jan 26, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $13 → $15 | Buy | Maintains | $13 → $15 | -29.97% | Jan 5, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | -25.30% | Jan 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $13 | Buy | Reiterates | $13 | -39.31% | Dec 27, 2023 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $12 → $15 | Buy → Strong Buy | Upgrades | $12 → $15 | -29.97% | Dec 27, 2023 |